Biblio Discovery — Demo Discovery Service

81 hasil untuk "Brisson, Marc"

Menampilkan 1–20 · 1,00 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Estimating the Number Needed to Vaccinate to Prevent Herpes Zoster-related Disease, Health Care Resource Use and Mortality

    Brisson, Marc

    Can J Public Health · 2008 · Inggris · PubMed Central

    BACKGROUND: A clinical trial has shown that a live-attenuated varicella-zoster virus vaccine is effective against herpes zoster (HZ) and post-herpetic neuralgia (PHN). The aim of the study was to estimate the number needed to vaccinate (NNV) to prevent HZ-related outcomes. METHODS: A cohort model…

  2. Artikel Jurnal Teks lengkap

    Potential lives saved in 73 countries by adopting multi‐cohort vaccination of 9–14‐year‐old girls against human papillomavirus

    Jit, Mark; Brisson, Marc

    Int J Cancer · 2018 · Inggris · PubMed Central

    Up to 2016, low‐ and middle‐income countries mostly introduced routine human papillomavirus (HPV) vaccination for just a single age‐cohort of girls each year. However, high‐income countries have reported large reductions in HPV prevalence following “catch‐up” vaccination of multiple age‐cohorts in…

  3. Artikel Jurnal Teks lengkap

    Modelling the Epidemiology of Infectious Diseases for Decision Analysis

    Jit, Mark; Brisson, Marc

    Pharmacoeconomics · 2012 · Inggris · PubMed Central

    The number of economic evaluations related to infectious disease topics has increased over the last 2 decades. However, many such evaluations rely on models that do not take into account unique features of infectious diseases that can affect the estimated value of interventions against them. These…

  4. Artikel Jurnal Teks lengkap

    Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior

    Baussano, Iacopo; Lazzarato, Fulvio; Brisson, Marc dkk.

    Emerg Infect Dis · 2016 · Inggris · PubMed Central

    Human papillomavirus (HPV) prevalence varies widely worldwide. We used a transmission model to show links between age-specific sexual patterns and HPV vaccination effectiveness. We considered rural India and the United States as examples of 2 heterosexual populations with traditional age-specific…

  5. Artikel Jurnal Teks lengkap

    From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectiveness

    Jit, Mark; Prem, Kiesha; Benard, Elodie dkk.

    Prev Med · 2021 · Inggris · PubMed Central

    The Director-General of the World Health Organization has called for global action towards elimination of cervical cancer as a public health problem. Cervical cancer is caused by human papillomavirus (HPV), an infectious agent with no non-human reservoir. One way to achieve this is through very…

  6. Artikel Jurnal Teks lengkap

    Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis

    Drolet, Mélanie; Bénard, Élodie; Pérez, Norma dkk.

    Lancet · 2019 · Inggris · PubMed Central

    BACKGROUND: More than 10 years have elapsed since human papillomavirus (HPV) vaccination was implemented. We did a systematic review and meta-analysis of the population-level impact of vaccinating girls and women against human papillomavirus on HPV infections, anogenital wart diagnoses, and…

  7. Artikel Jurnal Teks lengkap

    Effect of HPV on cervical cancer screening in Alberta

    Brisson, Marc; Drolet, Mélanie; Bénard, Élodie dkk.

    CMAJ · 2016 · Inggris · PubMed Central

  8. Artikel Jurnal Teks lengkap

    Deaths from chickenpox

    Brisson, Marc; Edmunds, W John; Gay, Nigel J dkk.

    BMJ · 2002 · Inggris · PubMed Central

  9. Artikel Jurnal Teks lengkap

    Bias Due to Correlation Between Times-at-Risk for Infection in Epidemiologic Studies Measuring Biological Interactions Between Sexually Transmitted Infections: A Case Study Using Human Papillomavirus Type Interactions

    Malagón, Talía; Lemieux-Mellouki, Philippe; Laprise, Jean-François dkk.

    Am J Epidemiol · 2016 · Inggris · PubMed Central

    The clustering of human papillomavirus (HPV) infections in some individuals is often interpreted as the result of common risk factors rather than biological interactions between different types of HPV. The intraindividual correlation between times-at-risk for all HPV infections is not generally…

  10. Artikel Jurnal Teks lengkap

    Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model

    Jit, Mark; Brisson, Marc; Laprise, Jean-François dkk.

    BMJ · 2015 · Inggris · PubMed Central

    Objective To investigate the incremental cost effectiveness of two dose human papillomavirus vaccination and of additionally giving a third dose. Design Cost effectiveness study based on a transmission dynamic model of human papillomavirus vaccination. Two dose schedules for bivalent or…

  11. Artikel Jurnal Teks lengkap

    HPV vaccination and sexual behaviour in healthcare seeking young women in Luxembourg

    Soudeyns, Camille; Speybroeck, Niko; Brisson, Marc dkk.

    PeerJ · 2020 · Inggris · PubMed Central

    INTRODUCTION: Human papillomavirus (HPV) is the most common sexually transmitted infection (STI) worldwide. Despite recommendations for HPV vaccination of young women from health authorities, parental concerns were raised whether vaccination could induce unsafe sexual behaviour in young women…

  12. Artikel Jurnal Teks lengkap

    Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study

    Abbas, Kaja M; van Zandvoort, Kevin; Brisson, Marc dkk.

    Lancet Glob Health · 2020 · Inggris · PubMed Central

    BACKGROUND: The Papillomavirus Rapid Interface for Modelling and Economics (PRIME) has been used around the world to assess the health impact and cost-effectiveness of human papillomavirus (HPV) vaccination in girls. We updated PRIME with new data and methods for demography, disability weights, and…

  13. Artikel Jurnal Teks lengkap

    Optimal human papillomavirus vaccination strategies in the context of vaccine supply constraints in 100 countries

    Prem, Kiesha; Cernuschi, Tania; Malvolti, Stefano dkk.

    eClinicalMedicine · 2024 · Inggris · PubMed Central

    BACKGROUND: Countries are recommended to immunise adolescent girls routinely with one or two doses of human papillomavirus (HPV) vaccines to eliminate cervical cancer as a public health problem. With most existing vaccine doses absorbed by countries (mostly high-income) with existing HPV…

  14. Artikel Jurnal Teks lengkap

    Modeling Cervical Cancer Prevention in Developed Countries

    Kim, Jane J.; Brisson, Marc; Edmunds, W. John dkk.

    Vaccine · 2008 · Inggris · PubMed Central

    Cytology-based screening has reduced cervical cancer mortality in countries able to implement, sustain and financially support organized programs that achieve broad coverage. These ongoing secondary prevention efforts considerably complicate the question of whether vaccination against Human…

  15. Artikel Jurnal Teks lengkap

    Impact and Cost-effectiveness of 3 Doses of 9-Valent Human Papillomavirus (HPV) Vaccine Among US Females Previously Vaccinated With 4-Valent HPV Vaccine

    Chesson, Harrell W.; Laprise, Jean-François; Brisson, Marc dkk.

    J Infect Dis · 2016 · Inggris · PubMed Central

    Background. We estimated the potential impact and cost-effectiveness of providing 3-doses of nonavalent human papillomavirus (HPV) vaccine (9vHPV) to females aged 13–18 years who had previously completed a series of quadrivalent HPV vaccine (4vHPV), a strategy we refer to as “additional 9vHPV…

  16. Artikel Jurnal Teks lengkap

    Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection

    Brisson, Marc; Van de Velde, Nicolas; De Wals, Philippe dkk.

    CMAJ · 2007 · Inggris · PubMed Central

    BACKGROUND: A vaccine against human papillomavirus (HPV) types 6, 11, 16 and 18 is now licensed for use in Canada and many other countries. We sought to estimate the number needed to vaccinate to prevent HPV-related diseases and death. METHODS: A cohort model of the natural history of HPV infection…

  17. Artikel Jurnal Teks lengkap

    Mathematical Modeling of the Transmission Dynamics of Clostridium difficile Infection and Colonization in Healthcare Settings: A Systematic Review

    Gingras, Guillaume; Guertin, Marie-Hélène; Laprise, Jean-François dkk.

    PLoS One · 2016 · Inggris · PubMed Central

    BACKGROUND: We conducted a systematic review of mathematical models of transmission dynamic of Clostridium difficile infection (CDI) in healthcare settings, to provide an overview of existing models and their assessment of different CDI control strategies. METHODS: We searched MEDLINE, EMBASE and…

  18. Artikel Jurnal Teks lengkap

    Comparison of 2-Dose and 3-Dose 9-Valent Human Papillomavirus Vaccine Schedules in the United States: A Cost-effectiveness Analysis

    Laprise, Jean-François; Markowitz, Lauri E.; Chesson, Harrell W. dkk.

    J Infect Dis · 2016 · Inggris · PubMed Central

    A recent clinical trial using the 9-valent human papillomavirus virus (HPV) vaccine has shown that antibody responses after 2 doses are noninferior to those after 3 doses, suggesting that 2 and 3 doses may have comparable vaccine efficacy. We used an individual-based transmission-dynamic model to…

  19. Artikel Jurnal Teks lengkap

    Prevention strategies for herpes zoster and post-herpetic neuralgia

    Levin, Myron J.; Gershon, Anne A.; Dworkin, Robert H. dkk.

    J Clin Virol · 2010 · Inggris · PubMed Central

    Impairment of varicella zoster virus (VZV)-specific cell-mediated immunity, including impairment due to immunosenescence, is associated with an increased risk of developing herpes zoster (HZ), whereas levels of anti-VZV antibodies do not correlate with HZ risk. This crucial role of VZV-specific…

  20. Artikel Jurnal Teks lengkap

    Vaccinating Girls and Boys with Different Human Papillomavirus Vaccines: Can It Optimise Population-Level Effectiveness?

    Drolet, Mélanie; Boily, Marie-Claude; Van de Velde, Nicolas dkk.

    PLoS One · 2013 · Inggris · PubMed Central

    BACKGROUND: Decision-makers may consider vaccinating girls and boys with different HPV vaccines to benefit from their respective strengths; the quadrivalent (HPV4) prevents anogenital warts (AGW) whilst the bivalent (HPV2) may confer greater cross-protection. We compared, to a girls-only…